News on Contracture from BioPortfolio.com http://www.BioPortfolio.com Consolidated Contracture news from BioPortfolio.com Wed, 10 Feb 2010 10:59:39 GMT en BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025137&HITNO=0&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025137&THISHREF=http://c.moreover.com/click/here.pl%3fz2529450749%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025137&HITNO=0&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025137&THISHREF=http://c.moreover.com/click/here.pl%3fz2529450749%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Dupuytren Contracture Treatment Approvedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012950&HITNO=1&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012950&THISHREF=http://c.moreover.com/click/here.pl%3fz2523569496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012950&HITNO=1&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012950&THISHREF=http://c.moreover.com/click/here.pl%3fz2523569496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFacts & Comparisons: Medical News: Auxilium Announces U.S. Food And Drug Administration Approval For XIAFLEXTM For The Treatment Of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012707&HITNO=2&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012707&THISHREF=http://c.moreover.com/click/here.pl%3fz2523504632%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012707&HITNO=2&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012707&THISHREF=http://c.moreover.com/click/here.pl%3fz2523504632%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: US FDA Approves First Nonsurgical Treatment for Adult Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012447&HITNO=3&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012447&THISHREF=http://c.moreover.com/click/here.pl%3fz2523419237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012447&HITNO=3&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012447&THISHREF=http://c.moreover.com/click/here.pl%3fz2523419237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPSL Group: BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002735&HITNO=4&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002735&THISHREF=http://c.moreover.com/click/here.pl%3fz2519138072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002735&HITNO=4&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002735&THISHREF=http://c.moreover.com/click/here.pl%3fz2519138072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: Auxilium Pharmaceuticals, Inc.: Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002020&HITNO=5&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002020&THISHREF=http://c.moreover.com/click/here.pl%3fz2518678195%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002020&HITNO=5&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002020&THISHREF=http://c.moreover.com/click/here.pl%3fz2518678195%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: FDA OKs Dupuytren's Contracture Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009100&HITNO=6&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009100&THISHREF=http://c.moreover.com/click/here.pl%3fz2521831580%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009100&HITNO=6&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009100&THISHREF=http://c.moreover.com/click/here.pl%3fz2521831580%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPost Chronicle: Auxiliums Dupuytren Contracture Therapy Green-Lighted by FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008254&HITNO=7&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008254&THISHREF=http://c.moreover.com/click/here.pl%3fz2521472681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008254&HITNO=7&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008254&THISHREF=http://c.moreover.com/click/here.pl%3fz2521472681%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007939&HITNO=8&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007939&THISHREF=http://c.moreover.com/click/here.pl%3fz2521343925%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007939&HITNO=8&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007939&THISHREF=http://c.moreover.com/click/here.pl%3fz2521343925%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: US FDA Approves First Nonsurgical Treatment for Adult Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006473&HITNO=9&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006473&THISHREF=http://c.moreover.com/click/here.pl%3fz2520736882%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006473&HITNO=9&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006473&THISHREF=http://c.moreover.com/click/here.pl%3fz2520736882%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: FDA Oks Dupuytren's Contracture Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005823&HITNO=10&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005823&THISHREF=http://c.moreover.com/click/here.pl%3fz2520495095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005823&HITNO=10&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005823&THISHREF=http://c.moreover.com/click/here.pl%3fz2520495095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004824&HITNO=11&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004824&THISHREF=http://c.moreover.com/click/here.pl%3fz2520119228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004824&HITNO=11&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004824&THISHREF=http://c.moreover.com/click/here.pl%3fz2520119228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBaltimore Business Journal: BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004554&HITNO=12&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004554&THISHREF=http://c.moreover.com/click/here.pl%3fz2520016087%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004554&HITNO=12&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004554&THISHREF=http://c.moreover.com/click/here.pl%3fz2520016087%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004445&HITNO=13&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004445&THISHREF=http://c.moreover.com/click/here.pl%3fz2519967464%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004445&HITNO=13&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004445&THISHREF=http://c.moreover.com/click/here.pl%3fz2519967464%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMemphis Business Journal: BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytren's Contracturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004383&HITNO=14&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004383&THISHREF=http://c.moreover.com/click/here.pl%3fz2519926259%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004383&HITNO=14&MSIZE=83&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Contracture&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004383&THISHREF=http://c.moreover.com/click/here.pl%3fz2519926259%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCincinnati Business Journal: